HALO
HALOZYME THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$112.45
+2.53%Forward multiples
Based on analyst estimates
- P/E forward
- 11.77x
- P/E 2026E
- 13.24x
- P/E 2027E
- 10.82x
- P/E 2028E
- 9.51x
- P/S forward
- 6.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- 31.95x
- PEG TTM
- 0.18x
- Price / book
- 88.91x
- Price / sales
- 7.67x
- Price / cash flow
- 15.59x
Enterprise value
- Enterprise value
- $14.7B
- EV / sales
- 8.82x
- EV / EBITDA
- 20.56x
- EV / EBIT
- 15.54x
- Market cap
- $12.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026